Technical Analysis for FOMX - Foamix Pharmaceuticals Ltd.

Grade Last Price % Change Price Change
grade B 3.62 1.40% 0.05
FOMX closed up 1.4 percent on Friday, September 20, 2019, on 81 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical FOMX trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Shooting Star Candlestick Bearish 1.40%
Inside Day Range Contraction 2.26%
Outside Day Range Expansion 2.84%
NR7 Range Contraction 3.43%
NR7-2 Range Contraction 3.43%
NR7 Range Contraction 3.43%
Inside Day Range Contraction 3.43%

Older signals for FOMX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Foamix Pharmaceuticals Ltd., a clinical-stage specialty pharmaceutical company, develops and commercializes foam-based formulations acne, impetigo, and other skin conditions. Its lead product candidates include FMX101, which has completed a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo. The company is also developing FMX101 to treat rosacea; and FDX104 to treat chemotherapy-induced rashes, as well as early-stage foam formulations of various drugs for the treatment of dermatological indications, including antibacterial drugs, antifungal drugs, corticosteroids, and immunomodulators. Foamix Pharmaceuticals Ltd. has development and license agreements Bayer AG, Merz Pharmaceuticals, LLC, Actavis plc, Prestium Pharma, Inc. and Arkin Holdings Ltd., and others. It has operations in the United States, Germany, and Israel. The company was founded in 2003 and is headquartered in Rehovot, Israel.
Pharmaceutical Chemotherapy Acne Rosacea Anti Acne Preparations Impetigo
Is FOMX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.2
52 Week Low 1.97
Average Volume 824,632
200-Day Moving Average 3.224
50-Day Moving Average 2.8398
20-Day Moving Average 3.3355
10-Day Moving Average 3.536
Average True Range 0.2163
ADX 52.66
+DI 31.1276
-DI 9.0045
Chandelier Exit (Long, 3 ATRs ) 3.1411
Chandelier Exit (Short, 3 ATRs ) 3.5189
Upper Bollinger Band 3.8024
Lower Bollinger Band 2.8686
Percent B (%b) 0.8
BandWidth 27.995803
MACD Line 0.2052
MACD Signal Line 0.2036
MACD Histogram 0.0016
Fundamentals Value
Market Cap 135.48 Million
Num Shares 37.4 Million
EPS -1.33
Price-to-Earnings (P/E) Ratio -2.72
Price-to-Sales 40.32
Price-to-Book 2.30
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.89
Resistance 3 (R3) 3.89 3.79 3.85
Resistance 2 (R2) 3.79 3.72 3.79 3.83
Resistance 1 (R1) 3.71 3.68 3.75 3.71 3.82
Pivot Point 3.61 3.61 3.63 3.61 3.61
Support 1 (S1) 3.52 3.54 3.57 3.53 3.42
Support 2 (S2) 3.43 3.50 3.43 3.41
Support 3 (S3) 3.34 3.43 3.39
Support 4 (S4) 3.35